"Appetite Depressants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that are used to suppress appetite.
| Descriptor ID |
D001067
|
| MeSH Number(s) |
D27.505.954.427.140.155
|
| Concept/Terms |
Appetite Depressants- Appetite Depressants
- Depressants, Appetite
- Anorectics
- Anorexic Drugs
- Drugs, Anorexic
- Appetite Suppressants
- Suppressants, Appetite
- Appetite-Depressing Drugs
- Appetite Depressing Drugs
- Drugs, Appetite-Depressing
- Appetite-Suppressant Drugs
- Appetite Suppressant Drugs
- Drugs, Appetite-Suppressant
- Anorectic Agents
- Agents, Anorectic
- Anorexigenic Drugs
- Drugs, Anorexigenic
|
Below are MeSH descriptors whose meaning is more general than "Appetite Depressants".
Below are MeSH descriptors whose meaning is more specific than "Appetite Depressants".
This graph shows the total number of publications written about "Appetite Depressants" by people in this website by year, and whether "Appetite Depressants" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Appetite Depressants" by people in Profiles.
-
Levinson JA, Sarda V, Sonneville K, Calzo JP, Ambwani S, Austin SB. Diet Pill and Laxative Use for Weight Control and Subsequent Incident Eating Disorder in US Young Women: 2001-2016. Am J Public Health. 2020 01; 110(1):109-111.
-
Warren KR, Wehring HJ, Liu F, McMahon RP, Chen S, Chester C, Kelly DL. Effects of intranasal oxytocin on satiety signaling in people with schizophrenia. Physiol Behav. 2018 05 15; 189:86-91.
-
Warren KR, Buchanan RW, Feldman S, Conley RR, Linthicum J, Ball MP, Liu F, McMahon RP, Gorelick DA, Huestis MA, Kelly DL. Effects of the cannabinoid-1 receptor antagonist/inverse agonist rimonabant on satiety signaling in overweight people with schizophrenia: a randomized, double-blind, pilot study. J Clin Psychopharmacol. 2013 Feb; 33(1):118-20.
-
Ball MP, Warren KR, Feldman S, McMahon RP, Kelly DL, Buchanan RW. Placebo-controlled trial of atomoxetine for weight reduction in people with schizophrenia treated with clozapine or olanzapine. Clin Schizophr Relat Psychoses. 2011 Apr; 5(1):17-25.
-
Legendre O, Pecic S, Chaudhary S, Zimmerman SM, Fantegrossi WE, Harding WW. Synthetic studies and pharmacological evaluations on the MDMA ('Ecstasy') antagonist nantenine. Bioorg Med Chem Lett. 2010 Jan 15; 20(2):628-31.
-
Desai M, Gayle D, Han G, Ross MG. Programmed hyperphagia due to reduced anorexigenic mechanisms in intrauterine growth-restricted offspring. Reprod Sci. 2007 May; 14(4):329-37.
-
Soni MG, Burdock GA, Preuss HG, Stohs SJ, Ohia SE, Bagchi D. Safety assessment of (-)-hydroxycitric acid and Super CitriMax, a novel calcium/potassium salt. Food Chem Toxicol. 2004 Sep; 42(9):1513-29.
-
Ohia SE, Opere CA, LeDay AM, Bagchi M, Bagchi D, Stohs SJ. Safety and mechanism of appetite suppression by a novel hydroxycitric acid extract (HCA-SX). Mol Cell Biochem. 2002 Sep; 238(1-2):89-103.